Other Information
−Removed: Private Placement
−Removed: Between April 2, 2025 and April 25, 2025, the Company
−Removed: issued 3,500,000 units (each unit consisting of 1 share of common stock and 1 warrant to purchase 1/2 share of common stock at $0.01)
−Removed: to accredited investors in a private placement for gross proceeds of $35,000 at a price per share of $0.01.
−Removed: No solicitation was used in
−Removed: the offering.
−Removed: The Company relied on the exemption from registration available under Section 4(a)(2) of the 1933 Act and/or Rule 506(b)
−Removed: of Regulation D promulgated under the 1933 Act with respect to transactions by an issuer not involving any public offering.
−Removed: No commissions
−Removed: were paid in connection with these issuances of securities.
−Removed: The Company filed a Form D with the SEC on March 27, 2025 and an amended
−Removed: Form D with the SEC on May 14, 2025.
Rule 10b5-1 trading arrangements
−Removed: During the Company’s first quarter of 2025,
−Removed: no director or officer adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement.
+Added: During the Company’s second
+Added: quarter of 2025, no director or officer adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading
The following is a complete list of exhibits filed
12 unchanged sentences
Consultant Warrant
−Removed: Form of Warrant
Royalty Agreement between the Company and The Governors of the University of Alberta, dated April 8, 2015
24 unchanged sentences
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
+Added: August 13, 2025
PROTOKINETIX, INCORPORATED
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.